Comment
doi: 10.1136/annrheumdis-2016-210566.
Epub 2016 Oct 14.
Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor?
Affiliations
- PMID: 27742658
- DOI: 10.1136/annrheumdis-2016-210566
Item in Clipboard
Comment
Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor?
Ann Rheum Dis.
2017 Feb.
No abstract available
Keywords: Disease Activity; Rheumatoid Arthritis; Treatment.
Comment in
-
Response to: 'Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor?' by Nocturne et al.Ann Rheum Dis. 2017 Feb;76(2):e4. doi: 10.1136/annrheumdis-2016-210631. Epub 2016 Dec 1. Ann Rheum Dis. 2017. PMID: 27934677 No abstract available.
Comment on
-
Risk of lymphoma in patients exposed to antitumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.Ann Rheum Dis. 2017 Mar;76(3):497-503. doi: 10.1136/annrheumdis-2016-209389. Epub 2016 Aug 8. Ann Rheum Dis. 2017. PMID: 27502891 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
